The historical rank and industry rank for Verastem's OCF Margin % or its related term are showing as below:
LTS:0LOV'
s OCF Margin % Range Over the Past 10 Years
Min: -2606.04 Med: -793.53 Max: -37.85
Current: -304.42
During the past 13 years, the highest OCF Margin % of Verastem was -37.85%. The lowest was -2606.04%. And the median was -793.53%.
LTS:0LOV's OCF Margin % is ranked worse than 66% of 947
companies
in the Biotechnology industry
Industry Median: -64.23
vs LTS:0LOV: -304.42
Verastem OCF Margin % Related Terms
Verastem OCF Margin % Historical Data
* Premium members only.
The historical data trend for Verastem's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0LOV vs IRD, PALI, GALT: OCF Margin % Comparison
For the Biotechnology subindustry, Verastem's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verastem OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Verastem's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Verastem's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verastem (LTS:0LOV) has a OCF Margin % of -279.13% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Verastem and its competitors. According to the industry distribution chart, Verastem ranks #625 out of 947 companies in the Biotechnology industry, placing it in the top 66%.
Is Verastem's OCF Margin % too high?
Verastem's current OCF Margin % is -279.13%. Based on the distribution chart, Verastem ranks #625 out of 947 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Verastem has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verastem's OCF Margin % compare to IRD and PALI?
According to the Biotechnology industry distribution chart, Verastem ranks #625 out of 947 companies for OCF Margin %. This places Verastem in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Verastem and its competitors. Verastem's current OCF Margin % is -279.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verastem stock overvalued right now?
Based on GuruFocus' analysis, Verastem (LTS:0LOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.62, compared to a current price of $4.78 — trading 90.4% below its estimated fair value. The current OCF Margin % is -279.13%. Verastem's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Verastem (LTS:0LOV), the current OCF Margin % is -279.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verastem (LTS:0LOV) Overvalued in 2026?
Based on GuruFocus' analysis, Verastem stock appears to be undervalued.
The current stock price of $4.78 is trading 90.4% below its estimated GF Value™ of $49.62.
GuruFocus considers Verastem to be Possible Value Trap.
Key valuation signals for LTS:0LOV:
OCF Margin %: -279.13%
GF Value™: $49.62 vs. price of $4.78 (90.4% below fair value)
No single metric tells the full story. See the LTS:0LOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
23GF Score
Get the complete analysis for LTS:0LOV
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0LOV has been successfully added to your 
